Publicaciones en las que colabora con Marino Blanes Juliá (25)

2024

  1. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors

    Journal of Hepatology, Vol. 80, Núm. 6, pp. 904-912

2020

  1. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients

    Frontiers in Immunology, Vol. 11

  2. Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 8, pp. 379-389

  3. Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus

    Transplantation Reviews, Vol. 34, Núm. 2

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  2. Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

    Clinical Microbiology and Infection, Vol. 24, Núm. 2, pp. 192-198

2017

  1. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey

    Transplant Infectious Disease, Vol. 19, Núm. 6

  2. Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: Results of TRANSGRIPE 1-2, a randomized controlled clinical trial

    Clinical Infectious Diseases, Vol. 64, Núm. 7, pp. 829-838

2016

  1. Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 11, pp. 3220-3234

  2. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  3. Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study

    American Journal of Transplantation, Vol. 16, Núm. 7, pp. 2148-2157

2015

  1. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe

    Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1040.e11-1040.e18

2014

  1. Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: Study protocol for a multicenter, randomized, controlled clinical trial

    Trials, Vol. 15, Núm. 1

  2. Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): Experience from the RESITRA-REIPI cohort

    Transplant Infectious Disease, Vol. 16, Núm. 3, pp. 387-396

2012

  1. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort

    Transplant Infectious Disease, Vol. 14, Núm. 6, pp. 595-603

  2. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis c virus-coinfected liver transplant recipients: A FIPSE/GESIDA Prospective Cohort Study

    Liver Transplantation, Vol. 18, Núm. 1, pp. 70-81

  3. Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: A prospective and multicentre cohort study

    Transplant International, Vol. 25, Núm. 12, pp. 1275-1281

2011

  1. Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation

    Liver Transplantation, Vol. 17, Núm. 8, pp. 896-904

  2. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients

    Transplantation, Vol. 92, Núm. 3, pp. 346-350

2009

  1. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients

    Transplantation, Vol. 87, Núm. 3, pp. 424-435